FDA regulations make it harder to sue drug companiesBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7554.1350-b (Published 08 June 2006) Cite this as: BMJ 2006;332:1350
- David Spurgeon
The US Food and Drug Administration has added a preamble to its new regulations that will make it difficult for anyone to bring legal action against a drug manufacturer for harm caused by one of its products, says an article in this week's edition of the New England Journal of Medicine (2006; 354: 2409-11). The new regulations, which have attracted little publicity, come into effect on 30 June.
Along with modest alterations to drug labelling to be phased in over the next …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial